Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab

被引：0
|
作者：
Mariagrazia Lorenzin
Augusta Ortolan
Paola Frallonardo
Francesca Oliviero
Leonardo Punzi
Roberta Ramonda
机构：
[1] University of Padova,Rheumatology Unit, Department of Medicine – DIMED
来源：
BMC Musculoskeletal Disorders | / 16卷
关键词：
Spondyloarthritis; Ankylosing spondylitis; anti-TNFα agents; Biologic drugs; Infliximab;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Efficacy of infliximab in subgroups of patients with ankylosing spondylitis: Results from the ankylosing spondylitis study for the evaluation of recombinant infliximab therapy (ASSERT)
    Braun, J
    Maksymowych, WP
    Dougados, M
    Steinfeld, S
    Dewoody, K
    Williamson, P
    Van der Heijde, D
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 402 - 402
  • [42] Anti-infliximab Antibodies as a Marker of Drug Survival and Tapering in Ankylosing Spondylitis Patients: 12 Years Follow-up
    Pimentel, Clarissa
    Medeiros-Ribeiro, Cristina
    Shimabuco, Andrea
    Sampaio-Barros, Percival
    Moraes, Julio Cesar
    Schainberg, Claudia
    Goncalves, Celio
    Leon, Elaine
    Kuppa, Leonard
    Pasoto, Sandra
    Aikawa, Nadia
    Silva, Clovis
    Bonfa, Eloisa
    Saad, Carla
    ARTHRITIS & RHEUMATOLOGY, 2023, 75 : 5057 - 5057
  • [43] Body mass index influences the response to infliximab in ankylosing spondylitis
    Sébastien Ottaviani
    Yannick Allanore
    Florence Tubach
    Marine Forien
    Anaïs Gardette
    Blandine Pasquet
    Elisabeth Palazzo
    Marine Meunier
    Gilles Hayem
    Chantal Job-Deslandre
    André Kahan
    Olivier Meyer
    Philippe Dieudé
    Arthritis Research & Therapy, 14
  • [44] Body Mass Index Influences the Response to Infliximab in Ankylosing Spondylitis
    Ottaviani, Sebastien
    Allanore, Yannick
    Tubach, Florence
    Pasquet, Blandine
    Meyer, Olivier
    Dieude, Philippe
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S203 - S203
  • [45] Body mass index influences the response to infliximab in ankylosing spondylitis
    Ottaviani, Sebastien
    Allanore, Yannick
    Tubach, Florence
    Forien, Marine
    Gardette, Anais
    Pasquet, Blandine
    Palazzo, Elisabeth
    Meunier, Marine
    Hayem, Gilles
    Job-Deslandre, Chantal
    Kahan, Andre
    Meyer, Olivier
    Dieude, Philippe
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (03)
  • [46] IS THERE CLINICAL VALUE TO ANA MONITORING IN ANKYLOSING SPONDYLITIS PATIENTS TREATED WITH INFLIXIMAB? A RETROSPECTIVE AUDIT OF 70 PATIENTS
    Mathieson, Hannah R.
    Mackie, Sarah L.
    Bryer, Domini
    Buch, Maya
    Emery, Paul
    Marzo-Ortega, Helena
    RHEUMATOLOGY, 2013, 52 : 167 - 167
  • [47] Predictors of Response, Adverse Events and Treatment Retention in Ankylosing Spondylitis Patients Treated with Golimumab in a Prospective, Observational Registry
    Rahman, Proton
    Masetto, Ariel
    Teo, Michelle
    Boulos, Pauline
    Sholter, Dalton
    Kapur, Suneil
    Rampakakis, Emmanouil
    Rachich, Meagan
    Asin-Milan, Odalis
    Lehman, Allen
    Nantel, Francois
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [48] Association of Ankylosing Spondylitis and Crohn's Disease Successfully Treated with Infliximab
    Ana Isabel Castro de Sampaio Rebelo
    Sílvía Leite
    José Cotter
    BioDrugs, 2010, 24 : 37 - 39
  • [49] Association of Ankylosing Spondylitis and Crohn's Disease Successfully Treated with Infliximab
    Rebelo, Ana
    Leite, Silvia
    Cotter, Jose
    BIODRUGS, 2010, 24 : 37 - 39
  • [50] Change Over Time In The Profile Of Ankylosing Spondylitis Patients Treated With Infliximab In Canadian Routine Care
    Choquette, Denis
    Starr, Michael
    Khraishi, Majed M.
    Bensen, William G.
    Shaikh, Saeed A.
    Rodrigues, Jude F.
    Sholter, Dalton E.
    Sheriff, Maqbool K.
    Vaillancourt, Julie
    Sampalis, John S.
    Lehman, Allen J.
    Otawa, Susan M.
    Nantel, Francois
    Shawi, May
    ARTHRITIS AND RHEUMATISM, 2013, 65 : S1051 - S1051
12345